340-Blog

Big Pharma’s Threat to Poor Patients & 340B - Focus and Influence

On February 16, 2016,
Posted by Michael Burkhold
,

In: Blog

,
With 0 Comments

 According to Politico, “Nine of the 10 largest drug makers increased spending on lobbying Congress dropping more than $50 million on advocacy in 2015..., up from $46.7 million in 2014. PhRMA also increased lobbying spending from $16.5..

Read More

Big Pharma’s Strategy to Crush 340B

On February 15, 2016,
Posted by Michael Burkhold
,

In: Blog

,
With 0 Comments

For those who haven’t noticed, Big Pharma has a strategy to crush the the 340B program by eliminating the strongest 340B eligible organizations with a methodical misinformation campaign and then extinguishing the remainder at their..

Read More

Let’s Change the Conversation about the 340B Drug Program

On January 21, 2015,
Posted by admin
,

In: Blog

,
With 0 Comments
Like most anyone interested enough in this headline to move on to this post, I have been watching pharmaceutical companies use their significant lobbying and public relations resources to disparage the 340B drug program.  It seems the..
Read More
What's my program value?